09:16:36 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-08-14 Kvartalsrapport 2024-Q2
2024-03-07 X-dag ordinarie utdelning DEMANT 0.00 DKK
2024-03-06 Årsstämma 2024
2024-02-06 Bokslutskommuniké 2023
2023-08-15 Kvartalsrapport 2023-Q2
2023-03-09 X-dag ordinarie utdelning DEMANT 0.00 DKK
2023-03-08 Årsstämma 2023
2023-02-07 Bokslutskommuniké 2022
2022-08-16 Kvartalsrapport 2022-Q2
2022-03-11 X-dag ordinarie utdelning DEMANT 0.00 DKK
2022-03-10 Årsstämma 2022
2022-02-08 Bokslutskommuniké 2021
2021-08-12 Kvartalsrapport 2021-Q2
2021-03-08 X-dag ordinarie utdelning DEMANT 0.00 DKK
2021-03-05 Årsstämma 2021
2021-02-09 Bokslutskommuniké 2020
2020-08-17 Kvartalsrapport 2020-Q2
2020-03-11 X-dag ordinarie utdelning DEMANT 0.00 DKK
2020-03-10 Årsstämma 2020
2020-02-04 Bokslutskommuniké 2019
2019-08-14 Kvartalsrapport 2019-Q2
2019-03-20 X-dag ordinarie utdelning DEMANT 0.00 DKK
2019-03-19 Årsstämma 2019
2019-02-19 Bokslutskommuniké 2018
2018-08-15 Kvartalsrapport 2018-Q2
2018-03-23 X-dag ordinarie utdelning DEMANT 0.00 DKK
2018-03-22 Årsstämma 2018
2018-02-22 Bokslutskommuniké 2017
2017-08-14 Kvartalsrapport 2017-Q2
2017-05-09 Kvartalsrapport 2017-Q1
2017-03-28 X-dag ordinarie utdelning DEMANT 0.00 DKK
2017-03-27 Årsstämma 2017
2017-02-23 Bokslutskommuniké 2016
2016-11-10 Kvartalsrapport 2016-Q3
2016-08-17 Kvartalsrapport 2016-Q2
2016-05-25 Split DEMANT 1:5
2016-05-10 Kvartalsrapport 2016-Q1
2016-04-08 X-dag ordinarie utdelning DEMANT 0.00 DKK
2016-04-07 Årsstämma 2016
2016-03-01 Bokslutskommuniké 2015
2015-11-12 Kvartalsrapport 2015-Q3
2015-08-14 Kvartalsrapport 2015-Q2
2015-05-07 Kvartalsrapport 2015-Q1
2015-04-10 X-dag ordinarie utdelning DEMANT 0.00 DKK
2015-04-09 Årsstämma 2015
2015-02-26 Bokslutskommuniké 2014
2014-11-13 Kvartalsrapport 2014-Q3
2014-08-14 Kvartalsrapport 2014-Q2
2014-05-08 Kvartalsrapport 2014-Q1
2014-04-10 X-dag ordinarie utdelning DEMANT 0.00 DKK
2014-04-09 Årsstämma 2014
2014-02-27 Bokslutskommuniké 2013
2013-11-05 Kvartalsrapport 2013-Q3
2013-08-14 Kvartalsrapport 2013-Q2
2013-05-07 Kvartalsrapport 2013-Q1
2013-04-10 X-dag ordinarie utdelning DEMANT 0.00 DKK
2013-04-09 Årsstämma 2013
2013-02-26 Bokslutskommuniké 2012
2012-11-07 Kvartalsrapport 2012-Q3
2012-08-16 Kvartalsrapport 2012-Q2
2012-05-10 Kvartalsrapport 2012-Q1
2012-04-12 X-dag ordinarie utdelning DEMANT 0.00 DKK
2012-04-11 Årsstämma 2012
2012-02-29 Bokslutskommuniké 2011
2011-11-10 Kvartalsrapport 2011-Q3
2011-08-19 Kvartalsrapport 2011-Q2
2011-05-12 Kvartalsrapport 2011-Q1
2011-04-14 X-dag ordinarie utdelning DEMANT 0.00 DKK
2011-04-13 Årsstämma 2011
2010-11-16 Kvartalsrapport 2010-Q3
2010-04-08 X-dag ordinarie utdelning DEMANT 0.00 DKK

Beskrivning

LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriMedicinteknik
Demant är verksamt inom medicinteknik. Bolaget är specialiserat inom utveckling av hörapparater och hörslingor. Idag innehar bolaget verksamhet på global nivå där produkterna säljs under varierande varumärken. Produkterna nås via bolagets distributörer och försäljningskanaler. Utöver huvudverksamheten bedriver bolaget forskning inom diagnostik för mätning av hörselkvalitén. Bolaget grundades ursprungligen under 1904 och har sitt huvudkontor i Smörum.
2024-01-10 11:58:32

10.1.2024 11:58:29 CET | Demant A/S | Managers' Transactions

Company announcement no 2024-01

10 January 2024

Transactions with Demant shares by managers and

closely related parties

 

Notification pursuant to article 19 of the Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Søren Nielsen

2.

Reason for the notification

a)

Position/status

President & CEO

b)

Initial notification/amendment

Initial notification

3)

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Demant A/S

b)

LEI

213800RM6L9LN78BVA56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

 

Identification code

Shares

 

 

DK0060738599

b)

Nature of the transaction

Purchase of shares under share salary arrangement in accordance with section 7p of the Danish Tax Assessment Act, i.e. voluntary conversion of part of the remuneration into shares. Sign-up for participation in the arrangement was done at the beginning of 2023.

c)

Price(s) and volume(s)

Price(s)                            Volume(s)

 

Allocated shares in Q1:

 

DKK 194.88 per share        1,554 shares

 

The share price corresponds to the average share price quoted on Nasdaq Copenhagen in week 4 of 2023.

 

Allocated shares from April until December:

 

DKK 283.94 per share       369 shares

DKK 275.51 per share        380 shares

DKK 269.92 per share       388 shares

DKK 262.68 per share       398 shares

DKK 288.07 per share       363 shares

DKK 283.40 per share       369 shares

DKK 259.96 per share       402 shares

DKK 288.04 per share       363 shares

DKK 290.36 per share       360 shares

 

The share price corresponds to share price of the 8th trading day following the conclusion of the respective month.

d)

Aggregated information:

- Aggregated volume

- Price

 

Aggregated volume: 4,946 shares

Price: DKK 1,243,930.00

e)

Date of the transaction

8 January 2024

f)

Place of the transaction

Nasdaq Copenhagen A/S

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

René Schneider

2.

Reason for the notification

a)

Position/status

CFO

b)

Initial notification/amendment

Initial notification

3)

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Demant A/S

b)

LEI

213800RM6L9LN78BVA56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

 

Identification code

Shares

 

 

DK0060738599

b)

Nature of the transaction

Purchase of shares under share salary arrangement in accordance with section 7p of the Danish Tax Assessment Act, i.e. voluntary conversion of part of the remuneration into shares. Sign-up for participation in the arrangement was done at the beginning of 2023.

c)

Price(s) and volume(s)

Price(s)                            Volume(s)

 

Allocated shares in Q1:

 

DKK 194.88 per share        1,137 shares

 

The share price corresponds to the average share price quoted on Nasdaq Copenhagen in week 4 of 2023.

 

Allocated shares from April until December:

 

DKK 283.94 per share       267 shares

DKK 275.51 per share        273 shares

DKK 269.92 per share       279 shares

DKK 262.68 per share       286 shares

DKK 288.07 per share       261 shares

DKK 283.40 per share       265 shares

DKK 259.96 per share       289 shares

DKK 288.04 per share       261 shares

DKK 290.36 per share       259 shares

 

The share price corresponds to share price of the 8th trading day following the conclusion of the respective month.

d)

Aggregated information:

- Aggregated volume

- Price

 

Aggregated volume: 3,577 shares

Price: DKK 899,308.35

e)

Date of the transaction

8 January 2024

f)

Place of the transaction

Nasdaq Copenhagen A/S

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Niels Wagner

2.

Reason for the notification

a)

Position/status

President of Hearing Care

Member of the Executive Board

b)

Initial notification/amendment

Initial notification

3)

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Demant A/S

b)

LEI

213800RM6L9LN78BVA56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial

instrument, type of instrument

 

Identification code

Shares

 

 

DK0060738599

b)

Nature of the transaction

Purchase of shares under share salary arrangement in accordance with section 7p of the Danish Tax Assessment Act, i.e. voluntary conversion of part of the remuneration into shares. Sign-up for participation in the arrangement was done at the beginning of 2023.

c)

Price(s) and volume(s)

Price(s)                            Volume(s)

 

Allocated shares in Q1:

 

DKK 194.88 per share        901 shares

 

The share price corresponds to the average share price quoted on Nasdaq Copenhagen in week 4 of 2023.

 

Allocated shares from April until December:

 

DKK 283.94 per share       214 shares

DKK 275.51 per share        221 shares

DKK 269.92 per share       225 shares

DKK 262.68 per share       231 shares

DKK 288.07 per share       211 shares

DKK 283.40 per share       214 shares

DKK 259.96 per share       233 shares

DKK 288.04 per share       211 shares

DKK 290.36 per share       209 shares

 

The share price corresponds to share price of the 8th trading day following the conclusion of the respective month.

d)

Aggregated information:

- Aggregated volume

- Price

 

Aggregated volume: 2.870 shares

Price: DKK 722,250.02

e)

Date of the transaction

8 January 2024

f)

Place of the transaction

Nasdaq Copenhagen A/S

 

 

Further information:

Mathias Holten Møller, Head of Investor Relations

Peter Pudselykke, Investor Relations Officer

Henrik Axel Lynge Buchter, Communication Manager

 

Phone +45 3917 7300

www.demant.com

 

Contacts

  • Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com

About Demant A/S

Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.

Attachments